Insider at ACN (NYSE: ACN) files plan to sell 2,731 shares of Class A stock
Rhea-AI Filing Summary
A Form 144 notice reports that an affiliate of ACN, Manish Sharma, plans to sell 2,731 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of $786,870.47. The issuer has 660,432,542 shares of this class outstanding.
The shares to be sold were acquired from the issuer as stock awards on multiple dates in 2025 and 2026, including a grant of 1,502 shares on 12/05/2025. The filing also notes a prior sale by Manish Sharma of 6,902 Class A Ordinary shares on 10/22/2025, for gross proceeds of $1,725,546.93.
Positive
- None.
Negative
- None.
FAQ
How many ACN Class A Ordinary shares are planned for sale in this Form 144?
The Form 144 states that 2,731 Class A Ordinary shares of ACN are planned to be sold through UBS Financial Services, Inc. on the NYSE.
What is the aggregate market value of the ACN shares to be sold?
The planned sale covers 2,731 Class A Ordinary shares with an aggregate market value of $786,870.47, as reported in the Form 144.
When is the approximate sale date for the ACN shares in this Form 144?
The Form 144 lists an approximate date of sale of 01/14/2026 for the 2,731 Class A Ordinary shares on the NYSE.
How were the ACN shares being sold acquired by the insider?
The shares were acquired directly from the issuer as stock awards on several dates in 2025 and 2026, including grants such as 524 shares on 01/05/2026 and 1,502 shares on 12/05/2025.
Has Manish Sharma sold ACN shares in the last three months before this notice?
Yes. The document reports that Manish Sharma sold 6,902 Class A Ordinary shares on 10/22/2025, generating $1,725,546.93 in gross proceeds.
How many ACN Class A Ordinary shares are outstanding according to this filing?
The Form 144 states that there are 660,432,542 Class A Ordinary shares outstanding for the issuer.
Which broker and exchange are involved in the planned ACN share sale?
The planned sale is through UBS Financial Services, Inc. at 11 Madison Ave, 4th Floor, New York, NY 10010, and the shares are to be sold on the NYSE.